vs
Assertio Holdings, Inc.（ASRT）与M-tron Industries, Inc.（MPTI）财务数据对比。点击上方公司名可切换其他公司
M-tron Industries, Inc.的季度营收约是Assertio Holdings, Inc.的1.1倍（$14.2M vs $13.5M），M-tron Industries, Inc.同比增速更快（11.2% vs -57.9%），过去两年M-tron Industries, Inc.的营收复合增速更高（12.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
M-tron Industries, Inc.是一家研发生产高性能频率控制与计时解决方案的企业，产品涵盖晶体振荡器、滤波器、集成计时组件等，主要服务航空航天、国防、电信、工业自动化、医疗设备领域，客户覆盖北美、欧洲及亚洲的商业和政府机构。
ASRT vs MPTI — 直观对比
营收规模更大
MPTI
是对方的1.1倍
$13.5M
营收增速更快
MPTI
高出69.1%
-57.9%
两年增速更快
MPTI
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $14.2M |
| 净利润 | — | $3.4M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 27.3% |
| 净利率 | — | 24.1% |
| 营收同比 | -57.9% | 11.2% |
| 净利润同比 | — | 60.1% |
| 每股收益（稀释后） | $-4.54 | $0.90 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTMPTI
| Q4 25 | $13.5M | $14.2M | ||
| Q3 25 | $49.5M | $14.2M | ||
| Q2 25 | $29.2M | $13.3M | ||
| Q1 25 | $26.5M | $12.7M | ||
| Q4 24 | $32.2M | $12.8M | ||
| Q3 24 | $29.2M | $13.2M | ||
| Q2 24 | $31.1M | $11.8M | ||
| Q1 24 | $32.4M | $11.2M |
净利润ASRTMPTI
| Q4 25 | — | $3.4M | ||
| Q3 25 | $11.4M | $1.8M | ||
| Q2 25 | $-16.4M | $1.6M | ||
| Q1 25 | $-13.5M | $1.6M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-2.9M | $2.3M | ||
| Q2 24 | $-3.7M | $1.7M | ||
| Q1 24 | $-4.5M | $1.5M |
营业利润率ASRTMPTI
| Q4 25 | -86.7% | 27.3% | ||
| Q3 25 | 23.2% | 18.0% | ||
| Q2 25 | -27.5% | 13.9% | ||
| Q1 25 | -50.0% | 15.8% | ||
| Q4 24 | -41.9% | 20.1% | ||
| Q3 24 | -10.4% | 22.1% | ||
| Q2 24 | -11.6% | 17.8% | ||
| Q1 24 | -13.4% | 16.0% |
净利率ASRTMPTI
| Q4 25 | — | 24.1% | ||
| Q3 25 | 23.1% | 12.9% | ||
| Q2 25 | -56.0% | 11.7% | ||
| Q1 25 | -51.1% | 12.8% | ||
| Q4 24 | — | 16.7% | ||
| Q3 24 | -10.0% | 17.2% | ||
| Q2 24 | -11.8% | 14.8% | ||
| Q1 24 | -13.9% | 13.3% |
每股收益（稀释后）ASRTMPTI
| Q4 25 | $-4.54 | $0.90 | ||
| Q3 25 | $0.11 | $0.63 | ||
| Q2 25 | $-0.17 | $0.53 | ||
| Q1 25 | $-0.14 | $0.56 | ||
| Q4 24 | $-3.28 | $0.68 | ||
| Q3 24 | $-0.03 | $0.81 | ||
| Q2 24 | $-0.04 | $0.63 | ||
| Q1 24 | $-0.05 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $20.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $63.2M |
| 总资产 | $267.0M | $68.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTMPTI
| Q4 25 | $63.4M | $20.9M | ||
| Q3 25 | $93.4M | $18.3M | ||
| Q2 25 | $98.2M | $15.5M | ||
| Q1 25 | $87.3M | $13.7M | ||
| Q4 24 | $100.1M | $12.6M | ||
| Q3 24 | $88.6M | $8.5M | ||
| Q2 24 | $88.4M | $6.5M | ||
| Q1 24 | $80.7M | $5.4M |
总债务ASRTMPTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTMPTI
| Q4 25 | $94.0M | $63.2M | ||
| Q3 25 | $105.8M | $37.0M | ||
| Q2 25 | $93.3M | $34.8M | ||
| Q1 25 | $108.5M | $33.2M | ||
| Q4 24 | $121.1M | $31.3M | ||
| Q3 24 | $130.5M | $26.2M | ||
| Q2 24 | $132.2M | $23.7M | ||
| Q1 24 | $134.5M | $21.7M |
总资产ASRTMPTI
| Q4 25 | $267.0M | $68.4M | ||
| Q3 25 | $319.8M | $42.2M | ||
| Q2 25 | $273.8M | $39.7M | ||
| Q1 25 | $286.4M | $37.8M | ||
| Q4 24 | $284.7M | $36.6M | ||
| Q3 24 | $276.0M | $31.5M | ||
| Q2 24 | $279.4M | $28.4M | ||
| Q1 24 | $282.0M | $26.8M |
负债/权益比ASRTMPTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $2.7M |
| 自由现金流经营现金流 - 资本支出 | — | $2.3M |
| 自由现金流率自由现金流/营收 | — | 16.4% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.78× |
| 过去12个月自由现金流最近4个季度 | — | $8.1M |
8季度趋势，按日历期对齐
经营现金流ASRTMPTI
| Q4 25 | $-30.0M | $2.7M | ||
| Q3 25 | $-4.8M | $3.5M | ||
| Q2 25 | $19.1M | $2.9M | ||
| Q1 25 | $-12.5M | $1.6M | ||
| Q4 24 | $11.5M | $1.8M | ||
| Q3 24 | $-35.0K | $2.3M | ||
| Q2 24 | $7.4M | $2.0M | ||
| Q1 24 | $7.5M | $1.5M |
自由现金流ASRTMPTI
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $1.4M |
自由现金流率ASRTMPTI
| Q4 25 | — | 16.4% | ||
| Q3 25 | — | 19.1% | ||
| Q2 25 | — | 15.4% | ||
| Q1 25 | — | 8.0% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 13.4% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | 12.3% |
资本支出强度ASRTMPTI
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 4.6% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 0.0% | 3.6% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 1.1% |
现金转化率ASRTMPTI
| Q4 25 | — | 0.78× | ||
| Q3 25 | -0.42× | 1.92× | ||
| Q2 25 | — | 1.83× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.85× | ||
| Q3 24 | — | 0.99× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | — | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
MPTI
| US | $11.3M | 79% |
| Non Us | $2.9M | 21% |
